Kura Oncology, Inc. (KURA)

Kura Oncology Stock Forecast

Stock Price Forecast

The 9 analysts that cover Kura Oncology stock have a consensus rating of "Buy" and an average price target of $25.56, which forecasts a 161.62% increase in the stock price over the next year. The lowest target is $11 and the highest is $40.

Price Target: $25.56 (+161.62%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$11	$25.56	$25	$40
Change	+12.59%	+161.62%	+155.89%	+309.42%

Analyst Ratings

The average analyst rating for Kura Oncology stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	2	2	2	2	2	3
Buy	7	7	7	7	7	7
Hold	2	2	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	11	10	10	10	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Daniel Brims Lake Street	Lake Street	Strong Buy Initiates $23	Strong Buy	Initiates	$23	+135.41%	Apr 14, 2026
Mara Goldstein Mizuho	Mizuho	Buy Maintains $30 → $25	Buy	Maintains	$30 → $25	+155.89%	Mar 24, 2026
David Dai UBS	UBS	Strong Buy Maintains $16 → $15	Strong Buy	Maintains	$16 → $15	+53.53%	Mar 13, 2026
Robert Driscoll Wedbush	Wedbush	Buy Maintains $38 → $36	Buy	Maintains	$38 → $36	+268.47%	Mar 6, 2026
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $40	Strong Buy	Reiterates	$40	+309.42%	Jan 13, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

84.91M

Increased by 25.83%

from 67.48M

Revenue Next Year

173.16M

Increased by 103.92%

from 84.91M

EPS This Year

-3.88

from -3.18

EPS Next Year

-2.89

from -3.88

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	53.88M	67.48M	84.91M	173.16M
Revenue Growth	-	-	-	-	25.24%	25.83%	103.92%
EPS	-1.97	-2.03	-2.08	-2.02	-3.18	-3.88	-2.89
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	16	16

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	114.8M	294.7M
Avg	84.9M	173.2M
Low	49.0M	59.3M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	70.1%	247.1%
Avg	25.8%	103.9%
Low	-27.4%	-30.2%

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	-3.43	-1.51
Avg	-3.88	-2.89
Low	-4.21	-3.88

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.